×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
JSPR – jasper therapeutics, inc. - class a (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
JSPR
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/2
07:00 am
jspr
Jasper Therapeutics Reports Positive Preliminary Data from ETESIAN Study of Briquilimab in Asthma and Findings from BEACON Study Internal Investigation
High
Report
Jasper Therapeutics Reports Positive Preliminary Data from ETESIAN Study of Briquilimab in Asthma and Findings from BEACON Study Internal Investigation
12/1
05:32 pm
jspr
Jasper Therapeutics to Host an Investor Webinar on December 2nd to Present Preliminary Data from ETESIAN Study in Asthma and Findings from BEACON Study Investigation [Yahoo! Finance]
High
Report
Jasper Therapeutics to Host an Investor Webinar on December 2nd to Present Preliminary Data from ETESIAN Study in Asthma and Findings from BEACON Study Investigation [Yahoo! Finance]
12/1
04:30 pm
jspr
Jasper Therapeutics to Host an Investor Webinar on December 2nd to Present Preliminary Data from ETESIAN Study in Asthma and Findings from BEACON Study Investigation
High
Report
Jasper Therapeutics to Host an Investor Webinar on December 2nd to Present Preliminary Data from ETESIAN Study in Asthma and Findings from BEACON Study Investigation
11/18
12:00 pm
jspr
JSPR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Jasper Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Medium
Report
JSPR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Jasper Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
11/18
09:58 am
jspr
JSPR FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Announces that Jasper Therapeutics Investors Have Opportunity to Lead Class Action Lawsuit
Low
Report
JSPR FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Announces that Jasper Therapeutics Investors Have Opportunity to Lead Class Action Lawsuit
11/18
09:00 am
jspr
Portnoy Law Firm Announces Class Action on Behalf of Jasper Therapeutics, Inc. Investors
Medium
Report
Portnoy Law Firm Announces Class Action on Behalf of Jasper Therapeutics, Inc. Investors
11/18
07:40 am
jspr
Jasper Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – JSPR
Medium
Report
Jasper Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – JSPR
11/17
05:30 pm
jspr
Bragar Eagel & Squire, P.C. Reminds Stockholders of Jasper, KBR, Spirit, and Molina of the Upcoming Deadlines and Urges Investors to Contact the Firm
Low
Report
Bragar Eagel & Squire, P.C. Reminds Stockholders of Jasper, KBR, Spirit, and Molina of the Upcoming Deadlines and Urges Investors to Contact the Firm
Date
Time
Symbol
Company Name
Action
%Chg
11/10/2025
08:00 am
jspr
jasper therapeutics, inc. - class a
MISS
Report
-10.6%
jasper therapeutics, inc. - class a
8/13/2025
04:05 pm
jspr
jasper therapeutics, inc. - class a
MISS
Report
2.0%
jasper therapeutics, inc. - class a
5/12/2025
04:05 pm
jspr
jasper therapeutics, inc. - class a
MISS
Report
1.7%
jasper therapeutics, inc. - class a
2/27/2025
08:00 am
jspr
jasper therapeutics, inc. - class a
MISS
Report
-1.7%
jasper therapeutics, inc. - class a
Date
Time
Action
From
To
Firm
Impact
%Chg
9/22
09:21 am
Maintains
Market Outperform
Market Outperform
JMP Securities
Medium
Report
4.8%
9/22
09:21 am
Maintains
Market Outperform
Market Outperform
JMP Securities
Medium
Report
4.8%
Date
Time
Symbol
Headline
Impact
12/2
10:24 am
jspr
Form SCHEDULE 13G Jasper Therapeutics, Filed by: ACORN BIOVENTURES, L.P.
High
Report
Form SCHEDULE 13G Jasper Therapeutics, Filed by: ACORN BIOVENTURES, L.P.
12/2
07:07 am
jspr
Form 8-K Jasper Therapeutics, For: Dec 02
High
Report
Form 8-K Jasper Therapeutics, For: Dec 02
11/14
05:23 pm
jspr
Form SCHEDULE 13G/A Jasper Therapeutics, Filed by: Qiming U.S. Healthcare Fund II, L.P.
Medium
Report
Form SCHEDULE 13G/A Jasper Therapeutics, Filed by: Qiming U.S. Healthcare Fund II, L.P.
11/14
12:19 pm
jspr
Form SCHEDULE 13G Jasper Therapeutics, Filed by: T. Rowe Price Investment Management, Inc.
Medium
Report
Form SCHEDULE 13G Jasper Therapeutics, Filed by: T. Rowe Price Investment Management, Inc.
11/12
01:05 pm
jspr
Form SCHEDULE 13G/A Jasper Therapeutics, Filed by: KINGDON CAPITAL MANAGEMENT, L.L.C.
Low
Report
Form SCHEDULE 13G/A Jasper Therapeutics, Filed by: KINGDON CAPITAL MANAGEMENT, L.L.C.
11/10
08:17 am
jspr
Form 10-Q Jasper Therapeutics, For: Sep 30
Medium
Report
Form 10-Q Jasper Therapeutics, For: Sep 30
11/10
08:05 am
jspr
Form 8-K Jasper Therapeutics, For: Nov 10
High
Report
Form 8-K Jasper Therapeutics, For: Nov 10
11/7
12:45 pm
jspr
Form SCHEDULE 13G/A Jasper Therapeutics, Filed by: MORGAN STANLEY
Medium
Report
Form SCHEDULE 13G/A Jasper Therapeutics, Filed by: MORGAN STANLEY
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: